BONE MARROW EVALUATION PROCEDURE AND MORPHOLOGICAL ASSESSMENT WITH CYTOGENETICS PRESERVE

Bone Marrow Evaluation Procedure and Morphological Assessment with Cytogenetics Preservation is a comprehensive hematological diagnostic procedure designed to assess bone marrow health, identify blood disorders, and preserve samples for advanced cytogenetic analysis.

Bone marrow is the body's primary blood-forming tissue, responsible for producing red blood cells, white blood cells, and platelets. When abnormalities affect blood cell production, structure, or function, a detailed bone marrow examination becomes essential for accurate diagnosis and treatment planning.

This procedure typically involves obtaining a bone marrow aspirate and, when clinically indicated, a bone marrow biopsy. The collected samples are examined microscopically to evaluate cellular morphology, maturation patterns, marrow cellularity, and the presence of abnormal cells. In addition, a portion of the specimen is specially preserved for cytogenetic testing, which analyzes chromosomes to identify genetic abnormalities associated with hematological diseases.

Cytogenetic studies play a crucial role in diagnosing, classifying, prognosticating, and monitoring many blood cancers and bone marrow disorders.

Benefits of the Test

• Comprehensive assessment of bone marrow function
• Detects blood cancers and marrow disorders
• Preserves samples for chromosomal analysis
• Supports accurate diagnosis and disease classification
• Helps determine prognosis and treatment strategies
• Assists in monitoring disease progression and response to therapy

Why Doctors Recommend This Test

Doctors may recommend this evaluation for:

• Suspected leukemia
• Lymphoma involving the bone marrow
• Multiple myeloma evaluation
• Myelodysplastic syndromes (MDS)
• Myeloproliferative neoplasms (MPN)
• Unexplained anemia
• Persistent abnormal blood counts
• Bone marrow failure syndromes
• Cytopenias of unknown cause
• Follow-up of known hematological malignancies

The addition of cytogenetics preservation allows for advanced chromosome analysis that can identify important disease-specific genetic abnormalities.

Preparation Before Test

Preparation may include:

• Informing your doctor about medications and allergies
• Discussing blood-thinning medications
• Undergoing routine blood tests before the procedure
• Following instructions regarding sedation if required

The procedure is usually performed under local anesthesia to minimize discomfort.

Normal Reporting Time

Morphological Assessment:

3–7 working days

Cytogenetic Analysis:

7–21 working days, depending on laboratory processing and chromosome culture requirements.

Who Should Take This Test?

• Patients with suspected leukemia or lymphoma
• Individuals with unexplained abnormal blood counts
• Patients with bone marrow disorders
• Individuals requiring cytogenetic evaluation
• Patients with suspected myelodysplastic or myeloproliferative disorders
• Individuals undergoing hematology-oncology assessment

This comprehensive evaluation provides critical information that helps physicians establish an accurate diagnosis and develop personalized treatment plans.

Clinical Significance

The test may help diagnose:

• Acute lymphoblastic leukemia (ALL)
• Acute myeloid leukemia (AML)
• Chronic lymphocytic leukemia (CLL)
• Chronic myeloid leukemia (CML)
• Multiple myeloma
• Myelodysplastic syndromes (MDS)
• Myeloproliferative neoplasms (MPN)
• Aplastic anemia
• Bone marrow infiltration by lymphoma
• Plasma cell disorders

Cytogenetic analysis can detect chromosomal abnormalities such as translocations, deletions, duplications, and other genetic changes that influence diagnosis, prognosis, and treatment decisions.